[go: up one dir, main page]

AU2003300870A1 - Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same - Google Patents

Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same

Info

Publication number
AU2003300870A1
AU2003300870A1 AU2003300870A AU2003300870A AU2003300870A1 AU 2003300870 A1 AU2003300870 A1 AU 2003300870A1 AU 2003300870 A AU2003300870 A AU 2003300870A AU 2003300870 A AU2003300870 A AU 2003300870A AU 2003300870 A1 AU2003300870 A1 AU 2003300870A1
Authority
AU
Australia
Prior art keywords
polypeptides
methods
same
immunodeficiency virus
human immunodeficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300870A
Other versions
AU2003300870A8 (en
Inventor
Dennis R. Burton
Ralph Pantophlet
Ian Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU2003300870A1 publication Critical patent/AU2003300870A1/en
Publication of AU2003300870A8 publication Critical patent/AU2003300870A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003300870A 2002-12-11 2003-12-11 Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same Abandoned AU2003300870A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43286902P 2002-12-11 2002-12-11
US60/432,869 2002-12-11
US46535003P 2003-04-24 2003-04-24
US60/465,350 2003-04-24
PCT/US2003/039534 WO2004053100A2 (en) 2002-12-11 2003-12-11 Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same

Publications (2)

Publication Number Publication Date
AU2003300870A1 true AU2003300870A1 (en) 2004-06-30
AU2003300870A8 AU2003300870A8 (en) 2004-06-30

Family

ID=32511677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300870A Abandoned AU2003300870A1 (en) 2002-12-11 2003-12-11 Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same

Country Status (2)

Country Link
AU (1) AU2003300870A1 (en)
WO (1) WO2004053100A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006105993A2 (en) * 2005-04-05 2006-10-12 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Method for shielding functional sites or epitopes on proteins
WO2011028963A2 (en) * 2009-09-03 2011-03-10 Biological Mimetics, Inc. Immunogenic hiv composition
US11149069B2 (en) 2012-08-03 2021-10-19 Dana-Farber Cancer Institute, Inc. Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers
CA2908538A1 (en) * 2013-04-02 2014-10-09 Barton F. Haynes Recombinant production of hiv-1 envelope glycoproteins
US10245313B2 (en) * 2014-10-24 2019-04-02 Versitech Limited DNA motif compounds and methods for inducing specific antibodies and cellular immunity
US12162910B2 (en) * 2018-10-22 2024-12-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant gp120 protein with V1-loop deletion
TW202231277A (en) * 2019-05-21 2022-08-16 美商基利科學股份有限公司 Methods of identifying hiv patients sensitive to therapy with gp120 v3 glycan-directed antibodies
CN117568404B (en) * 2024-01-16 2024-03-15 四川大学华西医院 Multi-finger (toe) related gene segment, animal model construction method and application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0434713B1 (en) * 1988-09-13 1994-10-12 Chiron Corporation Hiv-1 envelope muteins lacking hypervariable domains
US5614612A (en) * 1990-03-09 1997-03-25 Haigwood; Nancy L. Purified gp120 compositions retaining natural conformation
US6103238A (en) * 1992-03-13 2000-08-15 President And Fellows Of Harvard College Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines
US5652138A (en) * 1992-09-30 1997-07-29 The Scripps Research Institute Human neutralizing monoclonal antibodies to human immunodeficiency virus
US5585250A (en) * 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies

Also Published As

Publication number Publication date
WO2004053100A3 (en) 2004-12-29
WO2004053100A2 (en) 2004-06-24
AU2003300870A8 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
AU2003235707A1 (en) Immunogenic preparations and vaccines on the basis of mrna
AU2003222347A1 (en) Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
AU2002344596A1 (en) Tubular titanium oxide particles, method for preparing the same, and use of the same
AU2003299819A1 (en) Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof
AU2003221704A1 (en) Immunogenic peptides, and method of identifying same
AU2001238501A1 (en) Selective destruction of cells infected with human immunodeficiency virus
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003286486A1 (en) Methods and compositions for immunization against hiv
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2003300870A1 (en) Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same
AU2002225509A1 (en) Production and of viruses, viral isolates and vaccines
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU2003278175A1 (en) Vaccines of enhanced immunogenicity, and methods for preparing such vaccines
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU2003302375A1 (en) Artificial joint, medical implant, and methods of producing the artificial joint and medical implant
AU2003248853A1 (en) Detection of drug-resistant human immunodeficiency virus
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU2002364696A1 (en) Crystalline neutrokine-alpha protein, method of preparation thereof, and method of use thereof
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
AU2960000A (en) Detection of human immunodeficiency virus
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection
AU2003261900A1 (en) Method of designing physiologically active peptide and use thereof
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU2526001A (en) 2-phenyl-quinoline derivatives, preparation method and therapeutic use thereof
AU2001270209A1 (en) Hiv-1 vaccines and screening methods therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase